Wednesday, November 11, 2009: 8:30 AM
Bayou D (Gaylord Opryland Hotel)
Description:
This session will focus on protein engineering for therapeutic applications with an emphasis on emerging topics and recent successes. Possible areas of interest include, but are not limited to, (1) advances in protein-based therapeutics, (2) proteins for cellular targeting and imaging, (3) proteins involved in disease pathology, and (4) protein-based biomaterials.
Sponsor:
Bioengineering
Chair:
Co-Chair:
9:10 AM
(381c)
Towards the Rational Design of p53 Stabilizing Drugs: Probing the Surface of the Oncogenic Y220C Mutant
9:30 AM
(381d)
Targeting the Vasculature of Solid Tumors with Enzyme/Prodrug and Methionine-Depletion Therapy
10:00 AM
(381e)
Direct Epitope Mapping of T Cells From Influenza A Virus Genome Using Yeasts Displaying MHC-Peptide Complexes as Artificial Antigen Presenting Cells
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division